Different transcriptional regulatory activities of Mycobacterium bovis and Mycobacterium tuberculosis PhoPR systems

Full text loading... Abstract Tuberculosis (TB) is an infectious disease that affects humans and animals. The pathogens that cause TB belong to the Mycobacterium tuberculosis Complex (MTBC), with Mycobacterium tuberculosis and Mycobacterium bovis as the main representatives of human- and animal-adapted strains, respectively. One key genetic regulator of the MTBC members is the PhoPR system, which controls many processes including the stress response, lipid metabolism and pathogenesis, among others. Previous studies identified a key G71I substitution in the M. bovis PhoR ortholog relative to M. tuberculosis PhoR and suggested that PhoPR might be non-functional in animal-adapted strains, but recent work has highlighted the functionality of PhoPR in M. bovis despite the G71I substitution. Here we compare the transcriptional effects of the PhoPR system of M. tuberculosis H37Rv and M. bovis AF2122/97 on an M. bovis AF2122/97 ΔphoPR knockout background. Our results show common patterns of gene expression between the two orthologs, but also clear differences in the expression of rubredoxin genes and lipid biosynthetic loci. This work adds on to the evidence that the PhoPR system is indeed functional in M. bovis, and suggests that PhoPR controls differential transcriptional programs that are important in adapting to human or animal different hosts. - Received: - Version Posted: Funding - Science Foundation Ireland (Award SFI/15/IA/3154) - Principal Award Recipient: Stephen V. Gordon - Biotechnology and Biological Sciences Research Council (Award BB/N004574/1) - Principal Award Recipient: Apoorva Bhatt - Biotechnology and Biological Sciences Research Council (Award BB/N004574/1) - Principal Award Recipient: Stephen V. Gordon - Science Foundation Ireland (Award SFI/15/IA/3154) - Principal Award Recipient: David E. MacHugh - Japan Agency for Medical Research and Development (AMED) (Award JP23jm0110021) - Principal Award Recipient: Chie Nakajima - Japan Agency for Medical Research and Development (AMED) (Award JP23jm0110021) - Principal Award Recipient: Yasuhiko Suzuki - Japan Agency for Medical Research and Development (AMED) (Award JP23jm0110021) - Principal Award Recipient: Gabriel Gonzalez - Japan Agency for Medical Research and Development (AMED) (Award JP20wm0125008) - Principal Award Recipient: Chie Nakajima - Japan Agency for Medical Research and Development (AMED) (Award JP20wm0125008) - Principal Award Recipient: Yasuhiko Suzuki - Japan Agency for Medical Research and Development (AMED) (Award JP20wm0125008) - Principal Award Recipient: Gabriel Gonzalez - Japan Agency for Medical Research and Development (AMED) (Award JP223fa627005) - Principal Award Recipient: Chie Nakajima - Japan Agency for Medical Research and Development (AMED) (Award JP223fa627005) - Principal Award Recipient: Yasuhiko Suzuki - Japan Agency for Medical Research and Development (AMED) (Award JP223fa627005) - Principal Award Recipient: Gabriel Gonzalez